Error: Could not add to watchlist. X

ZymoGenetics Inc

+ Watchlist
ZGEN:US
Acquired
ZGEN:US was acquired by BMY:US
USD
Volume
0
Volume
0
Current P/E Ratio (TTM)
-
Earnings per Share (USD) (TTM)
0.02
Market Cap (USD)
-
Shares Outstanding (m)
86.584
Price/Sales (TTM)
-
Dividend Indicated Gross Yield
-
Sector
Health Care
Industry
Biotech & Pharma
Sub-Industry
Specialty Pharma

Related Videos

There are currently no related videos for this ticker. Please check back later.
Profile
Zymogenetics, Inc. provides biopharmaceutical products. The Company researches and develops proprotein drugs that will significantly helps patients to fight against diseases. Zymogenetics conducts its operations in the United States.
ADDRESS
1201 Eastlake Avenue East
Seattle, WA 98102
United States
PHONE
1-206-442-6600
WEBSITE
-
  • Stephanie Feldt
    Dir:Market Insight
Show More